EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Translational Constraints and Next‐Generation Design of IL ‐6 Pathway Biologics in Inflammatory Bowel Disease

Philippe Pinton iD

Clinical and Translational Science · 2026-11 · 19 (11)

DOI: 10.1111/cts.70782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 17.11.2026. Verfasst von Philippe Pinton. Beteiligte Einrichtung: Shiroito Co., Ltd., Health & Life Sciences, Minato-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Interleukin-6, Recombinant Fusion Proteins, Biological Products. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Perspective examines why a subcutaneous version of olamkicept, a selective inhibitor of interleukin‐6 trans‐signaling, is still difficult to build from a full‐length Fc fusion. Using published pharmacokinetic data, a transparent dose calculation shows that clearance, not target abundance, sets the dose, and that half‐life is the most sensitive lever. Compact engineered formats are considered as design hypotheses, with working parameters for binding, volume, and viscosity. Four open questions are proposed before such formats advance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesInterleukin-6Recombinant Fusion ProteinsBiological ProductsInterleukin-6 InhibitorsHumansSignal TransductionAnimalsDrug Design

Stichwörter der Autor:innen

IL‐6 trans‐signalinginflammatory bowel diseasenanobodiesolamkiceptpharmacokineticsprotein engineeringsubcutaneous delivery

Substanzen

Interleukin-6Recombinant Fusion ProteinsolamkiceptBiological ProductsIL6 protein, humanInterleukin-6 Inhibitors

Autor:innen und Institutionen

  • Shiroito Co., Ltd., Health & Life Sciences, Minato-ku, Tokyo, Japan.

ORCID-Profile: Philippe Pinton

Zitieren

APA

Pinton, P. (2026). Translational Constraints and Next‐Generation Design of IL ‐6 Pathway Biologics in Inflammatory Bowel Disease. Clinical and Translational Science, 19(11). https://doi.org/10.1111/cts.70782

Vancouver

Pinton P. Translational Constraints and Next‐Generation Design of IL ‐6 Pathway Biologics in Inflammatory Bowel Disease. Clinical and Translational Science. 2026;19(11). doi:10.1111/cts.70782

BibTeX
@article{Pinton2026,
  author = {Pinton, Philippe},
  title = {Translational Constraints and Next‐Generation Design of IL ‐6 Pathway Biologics in Inflammatory Bowel Disease},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {11},
  doi = {10.1111/cts.70782}
}
Kostenlos starten →